Tech Company Financing Transactions
Xentria Funding Round
Xentria, based in Chicago, secured $25 million from private investors.
Transaction Overview
Company Name
Announced On
10/18/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to further strengthen the depth of its scientific and technical leadership and drive the clinical development process forward. Funds will also support next stage clinical development of XTMAB-16, including the launch of a global clinical trial in sarcoidosis expected to initiate in early 2023.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8700 W. Bryn Mawr 600S
Chicago, IL 60631
USA
Chicago, IL 60631
USA
Phone
Website
Email Address
Overview
Xentria is an innovative company whose primary focus is to build an expansive product pipeline of biologics and biosimilars. We are committed to help solve medical unmet needs through meaningful patient engagement and novel scientific strategy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Kirsten Anderson
President
Tom Shea
VP - General Counsel
Victoria Wohlfeil
VP - Operations
Jennifer Mokos
VP - R & D
Tom Matthews
VP - Regulatory Affairs
Noopur Singh
Browse more venture capital transactions:
Prev: 10/18/2022: Investmint venture capital transaction
Next: 10/18/2022: Feel venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs